Concord Wealth Partners Biohaven Pharmaceutical Holding CO Ltd. Transaction History
Concord Wealth Partners
- $710 Million
- Q3 2025
Shares
1 transactions
Others Institutions Holding BHVN
# of Institutions
10Shares Held
965KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL895KShares$7.43 Million7.59% of portfolio
-
Eaton Vance Management Boston, MA35.9KShares$298,0360.01% of portfolio
-
S. Muoio & Co. LLC New York, NY19KShares$157,5343.79% of portfolio
-
Agf Investments LLC Boston, MA11.6KShares$95,9480.16% of portfolio
-
Fny Investment Advisers, LLC2.3KShares$19,0900.01% of portfolio
About Biohaven Pharmaceutical Holding Co Ltd.
- Ticker BHVN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,645,000
- Market Cap $595M
- Description
- Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...